Human Papillomavirus (HPV) Low Risk by in situ Hybridization, Paraffin
2002896
 
Ordering Recommendation
Not recommended for clinical use. Preferred test is HPV high-risk in situ hybridization.
Mnemonic
HPVLOW ISH
Methodology
In situ Hybridization
Performed
Mon-Thu
Reported
2-5 days
New York DOH Approval Status
This test is New York DOH approved.
Specimen Required
Patient Preparation
 
Collect
Tissue.  
Specimen Preparation
Formalin fix (10% neutral buffered formalin) and paraffin embed tissue. Transport tissue block or 5 sections on "plus" (positively) charged or silanized slides. (Min: 3 slides) Protect from excessive heat.  
Storage/Transport Temperature
Room temperature. Ship in cooled container during summer months.  
Unacceptable Conditions
Specimens in fixative other than 10% neutral buffered formalin. Decalcified specimens.  
Remarks
 
Stability
Ambient: Indefinitely; Refrigerated: Indefinitely; Frozen: Unacceptable  
Reference Interval
Negative
Interpretive Data
This test detects genotypes: 6,11.

A negative result does not rule out the presence of an HPV genotype absent from the test panel, a low level infection, or specimen sampling error.

See Compliance Statement A: www.aruplab.com/CS
Note
CPT Code(s)
88365
Components
Component Test Code*Component Chart Name
2002895HPV Low Risk ISH Comment
2002999ISH Tissue Source
2003000ISH Reference Number
2003001H and E Slide Description
2003008HPV ISH Low Risk
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, contact interface support at interface.support@aruplab.com.
Cross References
  • HPV
  • HPV Low Risk ISH
  • HPV LR ISH
  • HPVLOW ISH
  • Human Papillomavirus
  • low-risk HPV ISH
  • LR-HPV ISH